145 related articles for article (PubMed ID: 28286613)
21. Prognosis in very young women with triple-negative breast cancer: retrospective study of 216 cases.
Liu Y; Xin T; Huang DY; Shen WX; Li L; Lv YJ; Jin YH; Song XW; Teng C; Jiang QY
Med Oncol; 2014 Dec; 31(12):222. PubMed ID: 25391919
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of Triple-Negative Breast Cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?
Agarwal G; Nanda G; Lal P; Mishra A; Agarwal A; Agrawal V; Krishnani N
World J Surg; 2016 Jun; 40(6):1362-72. PubMed ID: 26842691
[TBL] [Abstract][Full Text] [Related]
23. Triple-Negative Breast Cancer in Ghanaian Women: The Korle Bu Teaching Hospital Experience.
Der EM; Gyasi RK; Tettey Y; Edusei L; Bayor MT; Jiagge E; Gyakobo M; Merajver SD; Newman LA
Breast J; 2015; 21(6):627-33. PubMed ID: 26547900
[TBL] [Abstract][Full Text] [Related]
24. [Comparison of biological behavior between triple-negative breast cancer and non-triple- negative breast cancer].
Ma JG; Wang NJ; Yu WJ
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1729-32. PubMed ID: 22027778
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological, Treatment and Event-Free Survival Characteristics in a Moroccan Population of Triple-Negative Breast Cancer.
Mouh FZ; Slaoui M; Razine R; El Mzibri M; Amrani M
Breast Cancer (Auckl); 2020; 14():1178223420906428. PubMed ID: 32425539
[TBL] [Abstract][Full Text] [Related]
26. Are Basal-Like and Non-Basal-Like Triple-Negative Breast Cancers Really Different?
Dogra A; Mehta A; Doval DC
J Oncol; 2020; 2020():4061063. PubMed ID: 32256581
[TBL] [Abstract][Full Text] [Related]
27. Triple-negative breast cancer survival in Iranian patients.
Aghili M; Lashkari M; Farrokhpey AH; Izadi S
Acta Med Iran; 2013 Sep; 51(8):560-6. PubMed ID: 24026994
[TBL] [Abstract][Full Text] [Related]
28. [Safety of breast-conserving treatment for triple-negative breast cancer].
Wang L; Ouyang T; Wang T; Xie Y; Fan Z; Fan T; Li J
Zhonghua Wai Ke Za Zhi; 2015 Dec; 53(12):947-52. PubMed ID: 26850668
[TBL] [Abstract][Full Text] [Related]
29. Among triple-negative breast cancers, HER2(0) breast cancer shows a strong tendency to be basal-like compared with HER2(1+) breast cancer: preliminary results.
Nakagawa M; Bando Y; Nagao T; Takai C; Ohnishi T; Honda J; Moriya T; Izumi K; Takahashi M; Tangoku A; Sasa M
Breast Cancer; 2012 Jan; 19(1):54-9. PubMed ID: 21465226
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological and Prognostic Characteristics of Malaysian Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy Regimen.
Abdul Aziz AA; Md Salleh MS; Ankathil R
Int J Breast Cancer; 2020; 2020():8424365. PubMed ID: 32308997
[TBL] [Abstract][Full Text] [Related]
31. Triple-negative breast cancer is associated with EGFR, CK5/6 and c-KIT expression in Malaysian women.
Kanapathy Pillai SK; Tay A; Nair S; Leong CO
BMC Clin Pathol; 2012 Sep; 12():18. PubMed ID: 23009686
[TBL] [Abstract][Full Text] [Related]
32. Breast-conserving therapy for triple-negative breast cancer.
Gangi A; Chung A; Mirocha J; Liou DZ; Leong T; Giuliano AE
JAMA Surg; 2014 Mar; 149(3):252-8. PubMed ID: 24382582
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of EGFR and cytokeratin 5/6 immunohistochemical expression in triple-negative breast cancer.
Abdelrahman AE; Rashed HE; Abdelgawad M; Abdelhamid MI
Ann Diagn Pathol; 2017 Jun; 28():43-53. PubMed ID: 28648939
[TBL] [Abstract][Full Text] [Related]
34. Epidemiological Study of Triple-Negative Breast Cancer Patients in North Indian Population: a Hospital-Based Study.
Gupta M; Khanna S; Kumar M; Kar AG; Gupta SK
Indian J Surg Oncol; 2017 Sep; 8(3):279-283. PubMed ID: 36118385
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological features and prognosis of triple negative breast cancer in Kuwait: A comparative/perspective analysis.
Fayaz MS; El-Sherify MS; El-Basmy A; Zlouf SA; Nazmy N; George T; Samir S; Attia G; Eissa H
Rep Pract Oncol Radiother; 2014 May; 19(3):173-81. PubMed ID: 24936335
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological Features of Triple Negative Breast Carcinoma.
Reddy GM; Suresh PK; Pai RR
J Clin Diagn Res; 2017 Jan; 11(1):EC05-EC08. PubMed ID: 28273970
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer molecular subtypes and associations with clinicopathological characteristics in Iranian women, 2002- 2011.
Kadivar M; Mafi N; Joulaee A; Shamshiri A; Hosseini N
Asian Pac J Cancer Prev; 2012; 13(5):1881-6. PubMed ID: 22901141
[TBL] [Abstract][Full Text] [Related]
38. Tumor characteristics and recurrence patterns in triple negative breast cancer: a comparison between younger (<65) and elderly (≥65) patients.
Königsberg R; Pfeiler G; Klement T; Hammerschmid N; Brunner A; Zeillinger R; Singer C; Dittrich C
Eur J Cancer; 2012 Nov; 48(16):2962-8. PubMed ID: 22647688
[TBL] [Abstract][Full Text] [Related]
39. Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype.
Karihtala P; Auvinen P; Kauppila S; Haapasaari KM; Jukkola-Vuorinen A; Soini Y
Breast Cancer Res Treat; 2013 Feb; 138(1):81-90. PubMed ID: 23412770
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological significance of Sox10 expression in triple-negative breast carcinoma.
Jin L; Qin C; Qi X; Hong T; Yang X; Zhu X
Transl Cancer Res; 2020 Sep; 9(9):5603-5613. PubMed ID: 35117924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
